OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Investigator: Chien-liang Lin

4 Projects | 1 Researchers | $1,435,082 Invested

2018

The Ohio State University

Chien-liang Lin, PhD

Development of small molecule activators of glutamate transporter EAAT2 translation for Alzheimer's disease

  • Funding Amount: $794,918
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2016

The Ohio State University

Chien-liang Lin, PhD

Development of small molecule activators of glutamate transporter EAAT2 translation for AD (Year Three- bridge funding)

  • Funding Amount: $176,156
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2015

The Ohio State University

Chien-liang Lin, PhD

Development of small molecule activators of glutamate transporter EAAT2 translation for AD (year two)

  • Funding Amount: $244,008
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2013

The Ohio State University

Chien-liang Lin, PhD

Development of small molecule activators of glutamate transporter EAAT2 translation for Alzheimer's disease

  • Funding Amount: $220,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed